Paul Dixon – Acclime Australia
View Detailed Executive Profile →Professional Overview
Paul Dixon serves as an executive at Acclime Australia, overseeing strategic initiatives and leadership responsibilities.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| ESL | CFO & Company Secretary | Sep 2014 – Oct 2015 |
| PharmaSynth Pty Ltd | Company Secretary | Oct 2010 – Oct 2012 |
| Transmax Pty Ltd | Corporate Governance Consultant | Feb 2012 – Oct 2012 |
| Progen Pharmaceuticals Ltd (ASX: PGL, OTC: PGLA) | General Manager of Finance & Company Secretary | Dec 2008 – Oct 2012 |
| Acclime Australia | CFO | Jul 2011 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Acclime Australia corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Paul Dixon's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Acclime Australia's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)